Jonathan Leeman

11PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Instruments and techniquesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 09, 2026
Surveillance Versus Treatment for Favorable Intermediate-Risk Prostate Cancer and Mortality-Risk.

Mutlay Sayan, Yetkin Tuac, Zhiyu Qian

|May 16, 2025
Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer.

Tyler Walburn, Yetkin Tuaç, Çağdaş Aktan

|Dec 05, 2024
Biochemical response to neoadjuvant androgen deprivation therapy before radiation therapy and the risk of death in patients with unfavorable-risk prostate cancer: A secondary analysis of a randomized clinical trial.

Mutlay Sayan, Ming-Hui Chen, Jing Wu

|Jun 17, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancer.

Shehzad Basaria, Mary-Ellen Taplin, Marie McDonnell

|Nov 04, 2023
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.

Shalini Moningi, Atish D Choudhury, Neil E Martin

|Jul 24, 2023
Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: A systematic review and meta-analysis.

Jonathan E Leeman, Kee-Young Shin, Yu-Hui Chen

Pageof 2

Frequent Collaborators

2 joint publications

Eric J Sherman

2 joint publications

Paul L Nguyen

2 joint publications

Mutlay Sayan

1 joint publications

Evangelia Katsoulakis